18

January 18, 2015

MiRNA-based therapy for Human cancer: miRNA-5481 increases the expression of tumor suppressor p53 via down regulation of its target gene, 18/January/2015, 23.32

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, MiRNA-based therapy for Human cancer: miRNA-5481 increases the expression of tumor suppressor p53 via down regulation of […]
January 18, 2015

AntagomiR-based therapy for Metabolic diseases: MiRNA-224 suppresses the expression of MED13 and promotes insulin resistance and weight gain via up regulation of its target gene, 18/January/20145, 23.20

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, AntagomiR-based therapy for Metabolic diseases: MiRNA-224 suppresses the expression of MED13 and promotes insulin resistance and weight […]
January 18, 2015

Mechanistic insight into tumorigeneis: ULK suppresses the expression of tumor suppressor p53 via up regulation of its target gene, 18/January/2015, 23.01

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Mechanistic insight into tumorigeneis: ULK suppresses the expression of  tumor suppressor p53 via up regulation of its target […]
January 18, 2015

MiRNA-based therapy for Neurodegerative diseases: MiRNA-125b inhibits ageing-associated cognitive decline and neurodegeneration via down regulation of its target gene, 18/January/20145, 21.35

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, MiRNA-based therapy for Neurodegerative diseases: MiRNA-125b inhibits ageing-associated cognitive decline and neurodegeneration via down regulation of its […]